Methods: The primary objective of this study was to compare the rate of achieved therapeutic aPTT within 24 hours of initiating a weight-based UFH drip per protocol between obese and non-obese patients. The secondary objectives were to determine the difference in the mean dose of UFH at ...
for 5 min each, the blots were incubated with secondary antibody diluted in blocking buffer for 1 h at room temperature, washed six times in TBST for 5 min each, and developed using the T-pro LumiLong Chemiluminescence Detection kit (T-pro Biotech) according to the manufacturer's protocol....